Healthcare - Biotechnology - NASDAQ - US
$ 4.835
-0.103 %
$ 609 M
Market Cap
-3.81
P/E
Price Target
Average
41.33%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--32.89%
Net Income
Estimate
38.35%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Humacyte, Inc.
Wall Street analysts predict an average 1-year price target for HUMA of $6.83 , with forecasts ranging from a low of $4 to a high of $10 .
HUMA Lowest Price Target
Wall Street Target
4 USD
-17.27%
HUMA Average Price Target
Wall Street Target
6.83 USD
41.33%
HUMA Highest Price Target
Wall Street Target
10 USD
106.83%
REVENUE FORECAST
Revenue Forecast Chart HUMA
EBIT FORECAST
EBIT Forecast Chart HUMA
NET INCOME FORECAST
Net Income Chart HUMA